Arcus Biosciences, Inc.
RCUS· NYSE
Released Nov 5, 2019, after the close
10-Q filed Nov 5, 2019, 36 days after period end · 0001564590-19-040421
| Metric | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|
| Revenue | $1.75M | $4.29M | $163.00K |
| Net Income | -$22.35M | -$10.81M | -$23.12M |
| EPS Diluted | -$0.51 | -$0.25 | -$11.86 |
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.